Westchester Capital Management (New York)’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
Westchester Capital Management (New York)'s CCXI Position: Q4 2022 in Review
Westchester Capital Management (New York) sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 147,664 shares — an estimated $7.63M sold.
Westchester Capital Management (New York) first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $7.63M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Westchester Capital Management (New York) reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Westchester Capital Management (New York) sold 147,664 ChemoCentryx, Inc. shares in Q4 2022, an estimated $7.63M.
- Westchester Capital Management (New York) first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
- Westchester Capital Management (New York)'s ChemoCentryx, Inc. position peaked at $7.63M in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.